Resistance to ␤-lactams is constantly increasing due to the emergence of totally new enzymes but also to the evolution of preexisting ␤-lactamases. GES-1 is a clinically relevant extended-spectrum ␤-lactamase (ESBL) that hydrolyzes penicillins and broadspectrum cephalosporins but spares monobactams and carbapenems. However, several GES-1 variants (i.e., GES-2 and GES-5) previously identified among clinical isolates display an extended spectrum of activity toward carbapenems. To study the evolution potential of the GES-1 ␤-lactamase, this enzyme was submitted to in vitro-directed evolution, with selection on increasing concentrations of the cephalosporin cefotaxime, the monobactam aztreonam, or the carbapenem imipenem. The highest resistance levels were conferred by a combination of up to four substitutions. The A6T-E104K-G243A variant selected on cefotaxime and the A6T-E104K-T237A-G243A variant selected on aztreonam conferred high resistance to cefotaxime, ceftazidime, and aztreonam. Conversely, the A6T-G170S variant selected on imipenem conferred high resistance to imipenem and cefoxitin. Of note, the A6T substitution involved in higher MICs for all ␤-lactams is located in the leader peptide of the GES enzyme and therefore is not present in the mature protein. Acquired cross-resistance was not observed, since selection with cefotaxime or aztreonam did not select for resistance to imipenem, and vice versa. Here, we demonstrate that the ␤-lactamase GES-1 exhibits peculiar properties, with a significant potential to gain activity against broad-spectrum cephalosporins, monobactams, and carbapenems.
T he main mechanism of resistance to ␤-lactams in Gram negatives is the production of ␤-lactamases, which are classified into four molecular classes, A, B, C, and D, based on protein sequence analysis (1) . The enzymes belonging to classes A, C, and D are serine enzymes, while those belonging to class B are metalloenzymes requiring zinc ions for activity (2, 3) . Over the past 70 years, since the introduction of penicillins and cephalosporins, the massive use of broad-spectrum ␤-lactams has been at the origin of the selection of ␤-lactamases with broadened hydrolytic activities. The emergence of those broad-spectrum ␤-lactamases may correspond to three main phenomena: (i) the evolution of preexisting narrow-spectrum ␤-lactamases with an extension of their hydrolytic profile due to key amino acid substitutions, as observed for TEM and SHV ␤-lactamases, (ii) the acquisition of enzymes possessing intrinsic broad-spectrum hydrolytic activity, as observed for all CTX-M-type extended-spectrum ␤-lactamases (ESBLs) (4, 5) , and (iii) the evolution of broad-spectrum enzymes to expand or increase their hydrolytic activities to carbapenems.
GES-1 is an ESBL that was first identified in Klebsiella pneumoniae (6) and then extensively reported in clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii (7-10) but also frequently from the environment (11) (12) (13) . Similarly to other ESBLs, GES-1 hydrolyzes penicillins and broad-spectrum cephalosporins, spares carbapenems, and is susceptible to the activity of clavulanic acid as an inhibitor. However, in contrast to most ESBLs, GES-1 has low activity toward the broad-spectrum cephalosporin cefotaxime (CTX) and does not hydrolyze monobactams (6) . The GES family comprises 24 variants (GES-1 to GES-24) identified from clinical isolates, with some of them having amino acid substitutions conferring peculiar hydrolytic properties ( Table 1) . The G170N and G170S substitutions (Ambler numbering [1] ), located in the omega-loop of the enzyme and first described in GES-2 and GES-5, confer extended activities against carbapenems and cefoxitin (FOX) (against FOX only for G170S), decreased hydrolysis of broad-spectrum cephalosporins, and decreased susceptibility to ␤-lactam inhibitors (Table 1) (9, (14) (15) (16) . On the other hand, the E104K, G243A, and G243S substitutions, identified in several GES variants, have been shown to confer higher activities toward broad-spectrum cephalosporins and the monobactam aztreonam (ATM), together with increased susceptibilities to ␤-lactam inhibitors (Table 1) .
Given its ability to evolve, GES-1 was chosen as a model enzyme for testing the diversification potentials of ESBLs. Therefore, the GES-1 enzyme was subjected to directed evolution; this method consists of iterative rounds of random mutagenesis and selection and is commonly used for altering or optimizing protein function (17, 18) . GES-1 was submitted to three different ␤-lactam-based selective pressures, namely, the broad-spectrum cephalosporin CTX, ATM, or the carbapenem imipenem (IPM). A series of variants with increased and/or broadened specificities were selected, from which the causality between the increased hy-drolytic activity and the mutations could be inferred, and future evolutionary trajectories could be predicted.
MATERIALS AND METHODS

Construction and selection of mutagenized GES-1 libraries.
The pBSK-SII-kanR-GES-1 plasmid was used as the reference plasmid carrying genes coding for GES-1. Plasmid pBSKSII-kanR is derived from pBluescriptII (a high-copy-number plasmid, with 500 copies per cell) and carries a gene encoding resistance to kanamycin. The entire bla GES-1 -coding region (6) was amplified, the amplicon including 31 bp upstream of the ATG start up to the stop codon, with primers No50 (GES-1-HindIII-F, 5=-GATGAT AAGCTTACAAAGATAATTTCCATCTCAAGG-3=) and No51 (GES-1-NotI-R, 5=-GATGATGCGGCCGCCTATTTGTCCGTGCTCAGGATG-3=) (restriction sites HindIII and NotI are underlined), and cloned into the HindIII/NotI restriction sites of pBSKSII-kanR. The construct was verified by sequencing. Random mutagenesis was performed with the GenMorph II random mutagenesis kit (Agilent Technologies, Santa Clara, CA), using primers No50 and No51, according to the manufacturer's recommendations. The PCR-amplified mutagenized product was purified, digested, and ligated into the HindIII/NotI restriction sites of pBSK-SII-kanR. After purification, the ligation mixture was transformed into TOP10 electrocompetent Escherichia coli cells (Life Technologies, Zug, Switzerland). The library was plated on Luria-Bertani broth plates supplemented with 25 g/ml kanamycin. At each round, the complexity of the library was Ն10 5 independent clones. The mean substitution rate was 2 nucleotides per molecule, based on the sequencing of 10 clones. This corresponds to Ն6 ϫ 10 4 distinct sequences, as calculated using the library statistics program PEDEL (19) . For selection, the libraries were plated on increasing doses of the indicated antibiotic, in 2-fold increments. Plasmids recovered from the clones obtained with the highest antibiotic concentrations (usually 100 to 300 clones) were isolated, retransformed, and plated again with antibiotic at the same concentration. At this step, Ն4 clones were analyzed by sequencing, and the rest of the clones were isolated as a pool and used as a basis for the next round of random mutagenesis. Constructs with different combinations of mutations were made by subcloning or with the Q5 site-directed mutagenesis kit (New England BioLabs, Ipswich, MA).
MICs, specific hydrolytic activities, and IC 50 measurements. MICs were measured by Etest (bioMérieux, Marcy l'Etoile, France). Specific hydrolytic activities were measured from whole-cell extracts of recombinant E. coli strains producing the different GES variants, as described previously (6) . The assays were performed in 500 l total volume, using 150 M (for benzylpenicillin [PEN] , ATM, IPM, and FOX) or 75 M (for CTX and ceftazidime [CAZ]) substrate. Hydrolysis measurements were performed at room temperature with a Jenway spectrophotometer (Staffordshire, United Kingdom). The protein concentrations were measured with Bradford reagent (Sigma-Aldrich, Buchs, Switzerland). The results were expressed in nmol min Ϫ1 g Ϫ1 extract. The experiments were performed in triplicate from 3 independent cultures. The 50% inhibitory concentrations (IC 50 s) of hydrolysis activity were measured for clavulanic acid, using PEN as the substrate. A 3-min preincubation step with clavulanic acid was used before adding PEN. Those experiments were performed in triplicate from three independent cultures.
RESULTS
Selection of GES variants conferring increased resistance to
CTX, ATM, and IPM by directed evolution. GES mutants conferring increased resistance to CTX, ATM, or IPM were recovered c When available, the hydrolysis profile of each variant was estimated from published MICs. ϩ and Ϫ, hydrolysis and no hydrolysis, respectively, with dark-gray shaded cells indicating increased hydrolysis, and light-gray shaded cells indicating decreased hydrolysis, compared to wild-type GES-1. For each variant, the amino acid substitution responsible for the change in the hydrolytic profile is framed. Of note, these comparisons are only indicative, given that the bacterial species and the genetic support differ according to the study.
after three (for ATM and IPM) or four (for CTX) rounds of mutagenesis and selection. Over the rounds, the variants were successively selected with 1, 2, 4, and 16 g/ml CTX, 1, 16, 128, and 256 g/ml ATM, or 0.1, 0.125, and 0.25 g/ml IPM. Additional mutagenesis steps did not select variants with higher MICs. At the end of each round, at least four clones were sequenced. The mutations common to several clones were anticipated to be the phenotypically relevant ones, but additional substitutions, silent or not, did accumulate throughout the mutagenesis rounds. Therefore, some constructs were specifically generated to definitively correlate amino acid substitutions to resistance phenotypes (data not shown). The corresponding so-called cured variants (GES-C1 to -C5 for selection with CTX, GES-A1 to -A5 for selection with ATM, and GES-I1 to -I3 for selection with IPM) harboring the corresponding amino acid changes are depicted in Tables 2, 3 , and 4. The sequences of the originally isolated clones are listed in Table  S1 in the supplemental material. MICs of ␤-lactams for the selected mutants. Upon selection with CTX, the A6T substitution (clone GES-C1), located in the signal peptide, was the only mutation selected after round 1 ( Table  2) . At round 2, the E104K or G243S substitution was added to A6T (clones GES-C2 and GES-C3), and GES-C4 (A6T and G243A substitutions) was selected at round 3. A combination of the substitutions A6T, E104K, and G243A was selected at round 4 (clone GES-C5). The MICs of CTX for these constructs gradually increased during the directed evolution, from 0.75 g/ml for GES-1 to 48 g/ml for GES-C5 ( Table 2 ). The MICs of ATM and ceftazidime (CAZ) increased concomitantly to those of CTX, while the MICs of FOX, IPM, and the carbapenem ertapenem (ETP) remained unchanged (Table 2) . Four additional constructs were made to dissect the role of each amino acid change. E104K, G243S, or G243A single substitutions (clones GES-C6, GES-C7, and GES-C8, respectively) conferred lower resistance than that with A6T (clone GES-C1). The combination of E104K and G243A (clone GES-C9) was slightly more efficient than were single mutations ( Table 2) . Clone GES-C5, exhibiting the A6T, E104K, and G243A substitutions, combined three changes that individually conferred modest MIC increases but when combined together resulted in a variant for which the MIC of CTX reached 48 g/ml.
When selecting with ATM, the E104K (clone GES-A1) and G243A (clone GES-A2) single mutations were selected in round 1, while a combination of those two was selected at round 2 (clone GES-A3). Ultimately, the clones selected on ATM-128 additionally harbored a T237A substitution (E104K-T237A-G243A; clone GES-A4), and those selected on ATM-256 harbored the A6T substitution in addition to the three other changes (clone GES-A5) ( Table 3 ). The MICs of ATM for these constructs increased during the directed evolution, from 0.25 g/ml for GES-1 to Ͼ256 g/ml for clones GES-A4 and GES-A5. In parallel, the MICs of CAZ increased sharply, while those of CTX increased more modestly. No change was observed in the MICs of FOX, IPM, or ETP (Table  3) . Each of the three E104K, T237A, or G243A substitutions (clones GES-C6, GES-A6, and GES-A2, respectively) had slightly increased MICs of ATM (from 1.5 to 3 g/ml). Any dual combination resulted in higher MICs of ATM (from 12 or 32 g/ml, clones GES-A3, -A7 and -A8), while the triple mutant had an MIC of ATM of Ͼ256 g/ml (clone GES-A4) ( Table 3) . Of note, while the T237A substitution correlated with increased MICs of ATM and CAZ, it was systematically deleterious to the MIC of CTX. When selecting with IPM, the G170S substitution was selected at round 1 (clone GES-I1). Next, the C-1T substitution lying 1 bp before the ATG start codon (clone GES-I2) and, finally, the A6T substitution (clone GES-I3) were selected at rounds 2 and 3 (Table 4) . Overall, the MICs of IPM increased from 0.25 g/ml for wild-type GES-1 to 2 g/ml for clone GES-I3. The MICs of ETP and FOX increased con- comitantly, but conversely, the MICs of ATM, CTX, and CAZ were lowered once the G170S mutation was selected (Table 4) . In vitro-specific hydrolytic activities of the GES variants correlating with MIC values. In order to confirm that the higher MICs observed for the selected clones were indeed related to higher catalytic activities or a greater amount of the different GES enzymes selected, and not to a nonenzymatic resistance mechanism, the in vitro specific hydrolytic activities of a set of GES variants were determined. Overall, for all enzymes, the increased hydrolytic activities toward CTX, CAZ, ATM, IPM, and FOX correlated with the higher MICs of the corresponding substrates (Tables 2 to 4) .
Differential inhibition of the GES-selected variants by clavulanic acid. The IC 50 s of clavulanic acid were determined for a representative set of the GES variants. Clones GES-C1 and GES-C5 showed IC 50 s of clavulanic acid similar to those of the wild-type GES-1 clone (Table 2 ). However, clones GES-A4 and GES-A5 showed 10-fold lower IC 50 s (0.6 M) (Table 3) , likely due to the T237A substitution. Conversely, clones GES-I3 and GES-I4 selected on IPM and harboring the G170S substitution showed significantly higher IC 50 s (Table 4) . Overall, the mutants selected on CTX showed a susceptibility to clavulanic acid similar to that of GES-1, while the clones selected on ATM showed increased susceptibility to clavulanic acid, and clones selected on IPM showed lower susceptibility to clavulanic acid.
DISCUSSION
The directed evolution procedure used here combined the generation of mutagenized libraries with antibiotic selection, and it allowed the selection of GES variants that may be categorized into two classes, with those selected on CTX or ATM conferring high resistance to CTX, ATM, and CAZ on one hand, and those selected on IPM conferring high resistance to IPM and FOX on the other hand.
Interestingly, the A6T substitution located in the signal sequence (18 amino acids long for GES-1) was selected through all three evolutionary routes. Of note, signal sequences are required for translocation to the periplasm (20) . The A6T substitution in GES-1 systematically conferred a 3-to 8-fold increase in the MICs of CTX, ATM, and IPM (Tables 2 to 4 ). In accordance with our observation, a study including experimental mutagenesis of a consensus signal sequence fused to a ␤-lactamase gene increased the ampicillin tolerance level of the host cell up to 8-fold (21) . To the best of our knowledge, it has never been clearly assessed that mutations in the signal sequence of any ␤-lactamase may confer increased resistance to ␤-lactams. The impact of such a substitution should therefore be further investigated as a mechanism leading to reduced susceptibility or even resistance to ␤-lactams.
By selecting with IPM, the G170S mutation located in the ⍀-loop of the catalytic site (amino acids 159 to 182), a highly conserved motif among the ␤-lactamases, was recovered. This substitution has been shown to confer a 100-fold increased catalytic activity against IPM compared to that with GES-1 (14, 22, 23) . The E104 residue is exposed near the entrance to the binding site, and the E104K substitution is commonly found in the TEM family, where this change participates in the expansion of the ␤-lactamase spectrum, and more strikingly when associated with other substitutions, such as R164S or G238S (24) (25) (26) . Despite several studies, the mechanism of this synergism remains poorly understood (26) . The G243A substitution is not conserved among ␤-lactamases, and this change might create subtle rearrangements in the disulfide bond. The T237 amino acid, together with the S70 residue, forms an oxyanion hole, which houses the ␤-lactam carbonyl of the acyl-enzyme intermediate (27) . Position 237, usually occupied by an Ala or Ser in most class A ␤-lactamases, corresponds to a Thr residue in GES-1 but also in the PER-1 ESBL and in the class A KPC-2 carbapenemase. It was experimentally shown with KPC-2 that a T237A change resulted in lower hydrolysis of CTX (28) . Conversely, in TEM, the natural or experimentally generated A237T substitution confers increased hydrolysis of CTX and decreased hydrolysis of CAZ and ATM (22, 29) . These observations correlate with the detrimental effect of the T237A substitution in GES on the hydrolysis of CTX, as well as the beneficial effect on the hydrolysis of CAZ and ATM.
The E104K, G170S, T237A, G243S, and G243A substitutions selected through our study were previously described in GES alleles identified from clinical isolates (Table 1) . Noticeably, the G170S substitution, which increases carbapenem hydrolysis, was previously identified in the natural carbapenemase GES-5. The E104K, T237A, and G243A substitutions were also identified in natural GES alleles, either alone (G243A in GES-9), associated with phenotypically uncharacterized mutations (GES-3, GES-7, GES-19, GES-22), or combined with other substitutions (GES-12 and GES-17) ( Table 1) . As inferred from our in vitro-directed evolution experiments, GES-5, GES-12, and GES-17 may therefore be prone to evolve into more active variants. On the other hand, some GES alleles recovered from clinical isolates had the G170S mutation, which confers higher activity toward carbapenems, combined with another mutation conferring increased activity toward CTX, ATM, and CAZ (see E104K and G170S in GES-6 and G243A and G170S in GES-14). Comparative studies showed that the increased hydrolysis of CTX, CAZ, or ATM mediated by E104K or G243A was abolished by the additional presence of G170S (30) (31) (32) . This precludes the possibility that the natural alleles GES-6 and GES-14 have been selected under successive distinct selective pressures. Similarly, a detailed analysis of the CTX-M-type ESBL potential evolutionary trajectories showed that the diversification process of the CTX-M variants can be explained only by selection with at least two antibiotics (33) .
Our study showed that GES enzymes can evolve into two types of variants conferring higher resistance to CTX, ATM, or IPM. The spontaneous evolution of antibiotic resistance is a multifactorial phenomenon, given the diversity of the genetic support of resistance genes, the bacterial strain (including potential changes in membrane permeability or in the penicillin-binding proteins), and the nature and concentration of the antibiotic. As a consequence, a higher number of possible mutations and evolutionary trajectories are possible, although they are constrained by intramolecular interactions (34) . Nevertheless, a good correlation between the in vitro prediction inferred from the analysis of the selected variants and that found in clinical isolates has been established here. Predictions regarding the occurrence of very efficient natural variants in term of catalytic efficiency using an in vitrodirected evolution were previously demonstrated for the TEM ␤-lactamase (34) (35) (36) (37) . From our study, we may speculate that selection with cephalosporins or monobactam might not select for GES variants possessing carbapenemase activity, and conversely, selection with the carbapenem IPM might not select for GES variants with increased hydrolytic activity toward CTX, CAZ, or ATM. Interestingly, as previously noticed with CTX-M-type ESBLs with increased activity toward broad-spectrum cephalosporins (38) , some antagonistic pleiotropy was observed, such as the decreased susceptibilities to ␤-lactamase inhibitors of some GES variants that exhibited increased catalytic activities toward carbapenems. Interestingly, this study reports for the first time the selection of ␤-lactamases possessing carbapenemase activities from ␤-lactamases lacking this property. Overall, such an approach sheds light on how clinical alleles have been selected and might predict the future evolutionary trajectories of the ␤-lactamases according to antibiotic selection pressure.
